Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity

Archives of Toxicology

Volumn 81, Issue 6, 2007, Pages 453-457

  Ghaznavi, R ^a   Kadkhodaee, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gentamicin; L NAME; L NIL; Nephrotoxicity; Nitric oxide

Indexed keywords

BETA N ACETYLGALACTOSAMINIDASE; CREATININE; GENTAMICIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N 6 (1 IMINOETHYL)LYSINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SECTION;

ACETYLGLUCOSAMINIDASE; ANIMALS; CREATININE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GENTAMICINS; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY DISEASES; LYSINE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34347257805     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-006-0157-2     Document Type: Article

References (22)

1. Andre M, Latado H, Felley-Bosco E (2005) Inducible nitric oxide synthase-dependent stimulation of PKGI and phosphorilation of VASP in human embryonic kidney cells. Biochem Pharmacol 69:595-602
2. Cenk C, Sen S, Boztok N, Tuglular I (2000) Proctective effects of oral l-arginine administration on gentamicin induced renal failure in rats. Eur J Pharmacol 390:327-334
3. Cuzzocrea R, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, De Sarro A, Pierpaoli S, Caputi A, Masini E, Salvemini D (2002) Eur J Pharmacol 450:67-76
4. Dehpour AR, Essalat M, Ala SH (1999) Increased by NO synthase inhibitor of lead-induced release of N-acetyl-b-d-glucosaminidase from perfused rat kidney. Toxicology 132:119-125
5. Gabbai FB (2001) Effects of nitric oxide synthesis blockers on renal function. Nephrol Dial Transplant suppl 1:10-13
6. Goligorsky MS, Gross SS (1997) Nitric oxide and the kidney. Chapman & Hall, New York, pp 22-38
7. Goligorsky MS, Budzikowski AS, Tsukahara H, Noiri E (2002) Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. Clin Exp Pharmacol Physiol 26:269-271
8. Herrera M, Garvin JL (2005) Recent advances in regulation of nitric oxide in the kidney. Hypertension 45:1062-1067
9. Holmqvist B, Olsson CF, Svensson ML, Svanborg C, Forsell J, Alm P (2005) Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4. J Mol Histol 36:499-516
10. Islas-Carbajal MC, Covarrubias A, Grijalva G, Alvarez-Rodriguez A, Armendariz-Borunda J, Rincon-Sanchez AR (2005) Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int 25:131-140
11. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY (2003) Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J Am Soc Nephrol. 14:389-396
12. Kone BC (2004) Nitric oxide synthesis in the kidney: isoforms, biosynthesis and functions in health. Semin Nephrol 24:299-315
13. Kumar U, Chen J, Sapoznikhov V, Canteros G, White BH, Sidhu A (2005) Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens 27:17-31
14. Rivas-Cabanero L, Montero A, Lopez Nova M (1994) Increased glomerular nitric oxide synthesis in gentamicin induced renal failure. Eur J Pharmacol 270:119-121
15. Rivas-Cabanero L, Rodriguez A, Arevalo M, Lopez-Novoa JM (1995) Effect of NG-nitro-l-arginine methyl ester on nephrotoxicity induced by gentamicin in rats. Nephron 71:203-207
16. Rivas-Cabanero L, Rodriguez A, Lopez Nova M, Martinez C (1997) Gentamicin treatment increases mesangial cell nitric oxide production. Exp Nephrol 5:23-30
17. Schwartz D, Brasowski E, Raskin Y, Schwartz IF, Wolman Y, Blum M, Blantz RC, Iaina A (2001) The outcome of non-selective vs. selective nitric oxide synthase inhibition in lipopolysaccharide treated rats. J Nephrol 14:110-114
18. Tolle M, Levkau B, Keul P, Brinkmann V, Giebing G, Schonfelder G, Schafers M, von Wnuck Lipinski K, Jankowski J, Jankowski V, Chun J, Zidek W, Van der Giet M (2005) Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res 96:913-920
19. Valdivielso JM, Rivas Cabanero L, Morales AI, Arevalo M, Lopez-Novoa JM, Perez-Barriconal F (1999) Increased renalglomerular endothelin-1 release in gentamicin-induced nephrotoxicity. Int J Exp Pathol 80:265-270
20. Walker RJ, Duggin G (1988) Drug nephrotoxicity. Annu Rev Pharmacol Toxicol 28:331-345
21. Yamasowa H, Shimizu S, Inoue T, Takaoka M, Matsumura Y (2005) Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 312:153-159
22. Zhang F, Siow YL, O K (2004) Hyperhomocysteinemia activates NF-kappaB and inducible nitric oxide synthase in the kidney. Kidney Int 65:1327-1338